MOLINA HEALTHCARE, INC. MOH
MOLINA HEALTHCARE, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45.4B | $40.6B | $34.1B | $32.0B | $27.8B | $19.4B | $16.8B | $18.9B | $19.9B | $17.8B |
| Gross profit | — | — | — | — | — | $2.5B | $2.3B | $2.5B | $1.8B | $1.7B |
| Operating income | $781.0M | $1.7B | $1.6B | $1.2B | $1.0B | $1.1B | $1.0B | $1.1B | -$555.0M | $306.0M |
| Interest expense | — | — | $109.0M | $110.0M | $120.0M | $102.0M | $87.0M | $115.0M | $118.0M | $101.0M |
| Income tax | $117.0M | $410.0M | $373.0M | $271.0M | $216.0M | $288.0M | $235.0M | $292.0M | -$100.0M | $153.0M |
| Net income | $472.0M | $1.2B | $1.1B | $792.0M | $659.0M | $673.0M | $737.0M | $707.0M | -$512.0M | $52.0M |
| EPS (diluted) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 |
| Operating cash flow | -$535.0M | $644.0M | $1.7B | $773.0M | $2.1B | $1.9B | $434.0M | -$314.0M | $804.0M | $673.0M |
| Free cash flow | -$636.0M | $544.0M | $1.6B | $682.0M | $2.0B | $1.8B | $377.0M | -$344.0M | $718.0M | $497.0M |
| Cash & equivalents | $4.2B | $4.7B | $4.8B | $4.0B | $4.4B | $4.2B | $2.5B | $2.8B | $3.2B | $2.8B |
| Total assets | $15.6B | $15.6B | $14.9B | $12.3B | $12.2B | $9.5B | $6.8B | $7.2B | $8.5B | $7.4B |
| Total liabilities | $11.5B | $11.1B | $10.7B | $9.3B | $9.6B | $7.4B | $4.8B | $5.5B | $7.1B | $5.8B |
| Shareholders' equity | $4.1B | $4.5B | $4.2B | $3.0B | $2.6B | $2.1B | $2.0B | $1.6B | $1.3B | $1.6B |
Growth · year-over-year · Revenue CAGR 11%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +11.7% | +19.3% | +6.6% | +15.1% | +43.0% | +15.4% | -10.9% | -5.0% | +11.8% | +25.4% |
| Net income growth | -60.0% | +8.1% | +37.8% | +20.2% | -2.1% | -8.7% | +4.2% | — | -1084.6% | -63.6% |
| EPS growth | -56.3% | +8.8% | +38.5% | +20.4% | +0.2% | -2.1% | +8.1% | — | -1085.9% | -64.3% |
| Free cash flow growth | -216.9% | -65.5% | +131.4% | -66.6% | +12.0% | +383.8% | — | -147.9% | +44.5% | -49.9% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.